Analyst Ratings for Liminal BioSciences, Inc. (LMNL)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2021 | H.C. Wainwright | Edwin Zhang | Downgrade | Neutral (Buy) |
N/A (N/A) |
4.07 (8.50) |
108.85% | Details |
| 6/2/2021 | Piper Sandler | Yasmeen Rahimi | Downgrade | Neutral (Overweight) |
4.50 (22.00) |
4.42 (8.50) |
92.31% | Details |
